Related Experiment Video
Updated: Nov 18, 2025

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease
Michelle T Lee1,2, Dhruv Mahtta1,2,3, Mahboob Alam3
1Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, USA.
Insights
Premature atherosclerotic cardiovascular disease (ASCVD) affects younger individuals, presenting unique challenges. Early identification and management of traditional and non-traditional risk factors are crucial for preventing disability and reducing healthcare costs.
Area of Science:
- Cardiology
- Vascular Medicine
- Preventive Cardiology
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is a leading global cause of mortality.
- While overall ASCVD mortality has decreased, younger populations have not seen similar improvements.
- Premature ASCVD poses a significant and growing challenge in healthcare.
Purpose of the Study:
- To review the literature on premature ASCVD.
- To identify and analyze risk factors specific to younger patients with ASCVD.
- To provide clinical insights for managing this demographic.
Main Methods:
- Literature search for studies on premature ASCVD.
- Definition of premature ASCVD: ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD), or peripheral arterial disease (PAD) in men ≤55 years and women ≤65 years.
- Synthesis of findings on risk factors and management strategies.
Main Results:
- Premature ASCVD patients frequently exhibit multiple traditional cardiovascular risk factors.
- Genetic predispositions and non-traditional factors like substance abuse and chronic inflammation are also implicated.
- Effective identification and management of at-risk younger individuals remain challenging for clinicians.
Conclusions:
- Aggressive control of traditional risk factors is essential in younger ASCVD patients.
- Optimization of primary and secondary prevention strategies is critical.
- Lifestyle modifications are imperative to reduce disability and costs associated with premature atherosclerosis.
Abstract:
Introduction: As the leading cause of death globally, atherosclerotic cardiovascular disease (ASCVD) carries substantial cost burden for patients and the healthcare system. Although overall mortality rates have recently decreased in certain groups, such improvements were not observed in younger ASCVD patients. This review focuses on premature ASCVD and explores risk factors affecting this younger cohort of patients.Areas covered: We performed a literature search for studies assessing premature ASCVD, defined as ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD), or peripheral arterial disease (PAD) occurring in men aged ≤55 years and women aged ≤65 years.Expert opinion: Premature ASCVD patients often suffer from multiple traditional cardiovascular risk factors, in addition to genetic predisposition or unique non-traditional features, such as substance abuse and chronic inflammatory conditions. Consequently, identification and management of at-risk individuals pose a great challenge for clinicians. In this younger patient cohort, control of traditional risk factors, optimization of primary and secondary prevention therapies, and lifestyle modifications are imperative to saving potential disability-adjusted life years and other costs associated with premature atherosclerosis.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

